Therapeutics means companies that invent new medicines, like pills and shots, to treat diseases. It is slow, costly, and risky.
Therapeutics companies research, test, and sell drugs that treat illness. Patients use the drugs, but insurers, governments, and hospitals usually pay the bill. Making one drug takes many years of lab work and human testing, and most candidates fail along the way.
AI tools can now scan huge amounts of biology data to suggest which drug targets might work, which used to take years of manual lab work. New methods like RNA-based drugs (using the molecule that carries genetic instructions) and engineered antibodies (immune proteins built to attack specific targets) also make it possible to aim at diseases that were hard to reach before.
AI-written from the public descriptions of the companies below. It can be wrong about details.
No startup here has grown past 150 people yet. The big players above are the ones to beat.
Startups are going after the slow, expensive way drugs get discovered. Many want AI to find better drug targets faster, or to design drugs for diseases that big companies skipped because the market looked too small or the science too hard. Incumbents have huge cash and trial networks, but their early research is often slow, crowded, and focused on proven markets. Most startups here are still early, and their claims are unproven until human trials show results.
Why you'd care: If you like biology, chemistry, or AI, this field hires a lot of scientists and engineers, and the work can help people directly. Investors put big money into it, so the field's direction affects which drugs you might take one day.
Nothing in the game here yet. Browse everything.
Nothing in the game here yet.